Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hsf4
|
ENSMUSG00000033249.4 | heat shock transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_105268120_105270091 | Hsf4 | 696 | 0.371875 | -0.37 | 3.4e-03 | Click! |
chr8_105272675_105272826 | Hsf4 | 2876 | 0.083336 | -0.37 | 4.1e-03 | Click! |
chr8_105271530_105271681 | Hsf4 | 1731 | 0.129506 | -0.34 | 8.6e-03 | Click! |
chr8_105270500_105271415 | Hsf4 | 1083 | 0.222127 | -0.30 | 2.0e-02 | Click! |
chr8_105267559_105267710 | Hsf4 | 2167 | 0.102748 | -0.26 | 4.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_48300015_48301474 | 13.97 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr3_14889110_14890285 | 8.45 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr18_35720849_35722653 | 7.81 |
Ecscr |
endothelial cell surface expressed chemotaxis and apoptosis regulator |
260 |
0.83 |
chr18_11051784_11053949 | 7.71 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr18_61651079_61652393 | 7.64 |
Mir143 |
microRNA 143 |
2478 |
0.16 |
chr6_86078066_86079298 | 7.54 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr13_4233789_4234486 | 7.46 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
397 |
0.81 |
chr8_23035959_23037041 | 7.02 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr6_60826003_60826617 | 6.85 |
Snca |
synuclein, alpha |
1246 |
0.48 |
chr9_50752994_50754649 | 6.68 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr2_173024069_173026002 | 6.66 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr1_51288641_51290950 | 6.14 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr11_75438634_75439472 | 6.14 |
Serpinf2 |
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
153 |
0.89 |
chr13_75709278_75709841 | 5.96 |
Ell2 |
elongation factor RNA polymerase II 2 |
1848 |
0.23 |
chr9_107982030_107984233 | 5.90 |
Gm20661 |
predicted gene 20661 |
38 |
0.54 |
chr1_135133209_135134183 | 5.83 |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
387 |
0.67 |
chr4_142017816_142018715 | 5.38 |
4930455G09Rik |
RIKEN cDNA 4930455G09 gene |
367 |
0.8 |
chr3_149497202_149497672 | 5.37 |
Gm30382 |
predicted gene, 30382 |
52136 |
0.17 |
chr15_75893368_75894708 | 5.31 |
Naprt |
nicotinate phosphoribosyltransferase |
252 |
0.8 |
chr18_62176067_62177775 | 5.30 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr1_45312046_45312607 | 5.24 |
Gm47302 |
predicted gene, 47302 |
653 |
0.46 |
chr9_110989233_110989717 | 5.22 |
Gm10030 |
predicted gene 10030 |
24 |
0.62 |
chr10_8944239_8945864 | 5.21 |
Gm48728 |
predicted gene, 48728 |
6898 |
0.2 |
chr10_58396489_58397099 | 5.19 |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
2406 |
0.3 |
chr6_31612888_31614126 | 5.13 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr14_48538424_48539155 | 5.13 |
4930572G02Rik |
RIKEN cDNA 4930572G02 gene |
430 |
0.76 |
chr19_7557459_7558480 | 5.07 |
Plaat3 |
phospholipase A and acyltransferase 3 |
484 |
0.77 |
chr6_41701642_41702158 | 5.04 |
Kel |
Kell blood group |
2439 |
0.19 |
chr15_98601965_98602724 | 5.02 |
Adcy6 |
adenylate cyclase 6 |
2387 |
0.14 |
chr10_77112255_77113959 | 4.98 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
chr17_29493756_29495031 | 4.95 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr4_86632574_86633020 | 4.90 |
Gm12551 |
predicted gene 12551 |
1546 |
0.33 |
chr6_136940269_136941762 | 4.89 |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
488 |
0.73 |
chr18_11049995_11051717 | 4.72 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr5_139793988_139794176 | 4.71 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
2548 |
0.18 |
chr6_41703661_41704308 | 4.63 |
Kel |
Kell blood group |
355 |
0.81 |
chr14_75178051_75179727 | 4.63 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr8_35377821_35378531 | 4.62 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
1516 |
0.31 |
chr2_43750582_43750808 | 4.59 |
Arhgap15 |
Rho GTPase activating protein 15 |
1825 |
0.5 |
chr11_115804413_115805142 | 4.58 |
Caskin2 |
CASK-interacting protein 2 |
3325 |
0.12 |
chr13_49308099_49309227 | 4.52 |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
577 |
0.76 |
chr3_137979675_137980041 | 4.51 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
1672 |
0.27 |
chr7_27448641_27448983 | 4.51 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
751 |
0.39 |
chr2_155612818_155614078 | 4.32 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2236 |
0.14 |
chr5_114969022_114970855 | 4.26 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr3_84189998_84191469 | 4.25 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr6_120174764_120175262 | 4.21 |
Ninj2 |
ninjurin 2 |
18810 |
0.18 |
chr8_67947181_67947785 | 4.21 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
4396 |
0.25 |
chr6_38355123_38355426 | 4.21 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
671 |
0.59 |
chr9_105520039_105521535 | 4.18 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr8_122282630_122283784 | 4.17 |
Zfpm1 |
zinc finger protein, multitype 1 |
1066 |
0.46 |
chr11_99437637_99438403 | 4.16 |
Krt20 |
keratin 20 |
130 |
0.92 |
chr1_40429769_40430295 | 4.15 |
Il1rl1 |
interleukin 1 receptor-like 1 |
462 |
0.83 |
chr5_116420481_116421179 | 4.15 |
Hspb8 |
heat shock protein 8 |
2034 |
0.22 |
chrX_150547515_150548479 | 4.13 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr12_102284220_102284371 | 4.13 |
Rin3 |
Ras and Rab interactor 3 |
654 |
0.75 |
chr6_47191483_47191919 | 4.07 |
Cntnap2 |
contactin associated protein-like 2 |
52686 |
0.16 |
chr2_105130039_105131439 | 4.07 |
Wt1 |
Wilms tumor 1 homolog |
61 |
0.97 |
chr8_122549282_122549435 | 4.04 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
1971 |
0.18 |
chr11_58199579_58200256 | 4.03 |
Irgm2 |
immunity-related GTPase family M member 2 |
299 |
0.49 |
chr12_32208046_32209200 | 4.02 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr2_28619735_28619886 | 4.02 |
Gfi1b |
growth factor independent 1B |
2135 |
0.19 |
chr14_31974812_31975096 | 4.01 |
4930425P05Rik |
RIKEN cDNA 4930425P05 gene |
38048 |
0.12 |
chr17_48454489_48455257 | 4.01 |
Unc5cl |
unc-5 family C-terminal like |
28 |
0.96 |
chrX_53053916_53055220 | 4.01 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr12_7978894_7979569 | 4.01 |
Apob |
apolipoprotein B |
1452 |
0.45 |
chr11_98446534_98448432 | 4.00 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr2_166080710_166081069 | 3.97 |
Sulf2 |
sulfatase 2 |
2770 |
0.25 |
chr7_128523279_128524917 | 3.96 |
Bag3 |
BCL2-associated athanogene 3 |
482 |
0.7 |
chr1_74000460_74000747 | 3.95 |
Tns1 |
tensin 1 |
964 |
0.63 |
chr16_77027836_77028095 | 3.93 |
Usp25 |
ubiquitin specific peptidase 25 |
14178 |
0.21 |
chr7_16844794_16846016 | 3.93 |
Prkd2 |
protein kinase D2 |
172 |
0.9 |
chr3_135828601_135828984 | 3.91 |
Slc39a8 |
solute carrier family 39 (metal ion transporter), member 8 |
2702 |
0.22 |
chr9_113970028_113970753 | 3.86 |
Gm47950 |
predicted gene, 47950 |
608 |
0.61 |
chr15_9079704_9079926 | 3.84 |
Nadk2 |
NAD kinase 2, mitochondrial |
4538 |
0.25 |
chr6_51129516_51130052 | 3.83 |
Mir148a |
microRNA 148a |
140126 |
0.04 |
chr6_87810021_87810172 | 3.81 |
Rab43 |
RAB43, member RAS oncogene family |
339 |
0.71 |
chr6_56901710_56902272 | 3.81 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
105 |
0.95 |
chr17_45592643_45594205 | 3.80 |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
210 |
0.86 |
chr14_59439561_59439794 | 3.79 |
Setdb2 |
SET domain, bifurcated 2 |
1196 |
0.33 |
chr7_37336508_37338401 | 3.78 |
6720469O03Rik |
RIKEN cDNA 6720469O03 gene |
29176 |
0.19 |
chr2_163548522_163549154 | 3.76 |
Hnf4a |
hepatic nuclear factor 4, alpha |
1245 |
0.35 |
chr16_92692883_92693516 | 3.74 |
Runx1 |
runt related transcription factor 1 |
2296 |
0.38 |
chr2_146098163_146098385 | 3.73 |
Cfap61 |
cilia and flagella associated protein 61 |
51023 |
0.15 |
chr6_88196136_88197817 | 3.71 |
Gata2 |
GATA binding protein 2 |
1358 |
0.32 |
chr15_66811887_66812132 | 3.69 |
Sla |
src-like adaptor |
584 |
0.76 |
chr13_5845041_5845796 | 3.69 |
1700016G22Rik |
RIKEN cDNA 1700016G22 gene |
12143 |
0.16 |
chr14_79518977_79519658 | 3.69 |
Elf1 |
E74-like factor 1 |
3619 |
0.2 |
chr10_45473706_45474109 | 3.67 |
Lin28b |
lin-28 homolog B (C. elegans) |
3706 |
0.27 |
chr1_189687202_189688055 | 3.66 |
Cenpf |
centromere protein F |
407 |
0.82 |
chr10_115817324_115818606 | 3.66 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr3_104640731_104641028 | 3.65 |
Gm43581 |
predicted gene 43581 |
2115 |
0.15 |
chr19_5842574_5845856 | 3.62 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr5_30913519_30915234 | 3.62 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr12_85686314_85687645 | 3.60 |
Batf |
basic leucine zipper transcription factor, ATF-like |
310 |
0.85 |
chr6_135199945_135200188 | 3.58 |
Fam234b |
family with sequence similarity 234, member B |
1654 |
0.23 |
chr7_49759364_49760048 | 3.56 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
553 |
0.79 |
chr6_129275114_129275355 | 3.56 |
Cd69 |
CD69 antigen |
132 |
0.94 |
chr15_78926966_78928482 | 3.56 |
Lgals1 |
lectin, galactose binding, soluble 1 |
998 |
0.29 |
chr4_40850475_40851213 | 3.55 |
Gm25931 |
predicted gene, 25931 |
442 |
0.43 |
chr2_170205245_170206276 | 3.54 |
Zfp217 |
zinc finger protein 217 |
57657 |
0.13 |
chr13_41017341_41017492 | 3.54 |
Tmem14c |
transmembrane protein 14C |
1124 |
0.37 |
chrX_150548577_150548762 | 3.51 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
1210 |
0.32 |
chr6_120819964_120820819 | 3.51 |
Atp6v1e1 |
ATPase, H+ transporting, lysosomal V1 subunit E1 |
1992 |
0.25 |
chr4_44982566_44983463 | 3.50 |
Grhpr |
glyoxylate reductase/hydroxypyruvate reductase |
1514 |
0.26 |
chr10_75937829_75938478 | 3.50 |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
933 |
0.28 |
chr15_6579077_6580099 | 3.48 |
Fyb |
FYN binding protein |
283 |
0.92 |
chr11_117779316_117780928 | 3.48 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr3_28698049_28698538 | 3.47 |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
276 |
0.91 |
chr13_41019834_41020226 | 3.46 |
Tmem14c |
transmembrane protein 14C |
3738 |
0.15 |
chr9_106157450_106158063 | 3.46 |
Glyctk |
glycerate kinase |
354 |
0.7 |
chr14_63268302_63270010 | 3.46 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chrX_73929866_73931201 | 3.46 |
Renbp |
renin binding protein |
208 |
0.88 |
chr11_101551182_101551915 | 3.45 |
Brca1 |
breast cancer 1, early onset |
34 |
0.9 |
chrX_12002735_12003732 | 3.44 |
Gm14512 |
predicted gene 14512 |
18765 |
0.23 |
chr11_12033577_12033953 | 3.43 |
Grb10 |
growth factor receptor bound protein 10 |
3636 |
0.27 |
chr3_146328120_146328802 | 3.43 |
Gm43334 |
predicted gene 43334 |
4041 |
0.21 |
chr8_105300988_105301570 | 3.43 |
E2f4 |
E2F transcription factor 4 |
2646 |
0.08 |
chr11_72409874_72410296 | 3.40 |
Smtnl2 |
smoothelin-like 2 |
1626 |
0.27 |
chr5_105731410_105732771 | 3.39 |
Lrrc8d |
leucine rich repeat containing 8D |
27 |
0.98 |
chr15_103257493_103257813 | 3.38 |
Nfe2 |
nuclear factor, erythroid derived 2 |
750 |
0.48 |
chr11_100969289_100970720 | 3.37 |
Cavin1 |
caveolae associated 1 |
547 |
0.68 |
chr15_84325346_84325775 | 3.37 |
Parvg |
parvin, gamma |
559 |
0.69 |
chr16_92824618_92824960 | 3.37 |
Runx1 |
runt related transcription factor 1 |
989 |
0.64 |
chrX_159302794_159303445 | 3.37 |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
162 |
0.97 |
chr13_60737782_60738368 | 3.35 |
Dapk1 |
death associated protein kinase 1 |
15921 |
0.15 |
chr17_34997593_34998230 | 3.31 |
Vars |
valyl-tRNA synthetase |
3076 |
0.07 |
chr7_143007094_143009025 | 3.30 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr11_102358807_102359649 | 3.27 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1340 |
0.27 |
chr11_102892824_102894139 | 3.26 |
Gfap |
glial fibrillary acidic protein |
3650 |
0.12 |
chr5_107724563_107727169 | 3.26 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr12_28622635_28623340 | 3.25 |
Colec11 |
collectin sub-family member 11 |
273 |
0.88 |
chr15_66811267_66811611 | 3.25 |
Sla |
src-like adaptor |
1154 |
0.5 |
chr2_10128810_10129045 | 3.25 |
Itih2 |
inter-alpha trypsin inhibitor, heavy chain 2 |
1736 |
0.25 |
chr4_136175397_136175565 | 3.24 |
E2f2 |
E2F transcription factor 2 |
3087 |
0.19 |
chr3_127931051_127931375 | 3.21 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
15041 |
0.14 |
chr19_4301696_4304008 | 3.19 |
Grk2 |
G protein-coupled receptor kinase 2 |
2356 |
0.14 |
chr19_43888532_43890580 | 3.19 |
Dnmbp |
dynamin binding protein |
1135 |
0.42 |
chr2_168049043_168050088 | 3.19 |
Gm24327 |
predicted gene, 24327 |
15332 |
0.13 |
chr8_84703616_84705950 | 3.18 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr2_4560599_4561970 | 3.18 |
Frmd4a |
FERM domain containing 4A |
1509 |
0.43 |
chr8_94898791_94899904 | 3.17 |
Ccdc102a |
coiled-coil domain containing 102A |
18174 |
0.1 |
chr9_57298408_57298964 | 3.16 |
Gm18996 |
predicted gene, 18996 |
30729 |
0.12 |
chr5_119673827_119675890 | 3.16 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr11_88998963_89000826 | 3.15 |
Trim25 |
tripartite motif-containing 25 |
518 |
0.65 |
chr19_5842021_5842539 | 3.15 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
2979 |
0.1 |
chr1_171388990_171389691 | 3.15 |
Arhgap30 |
Rho GTPase activating protein 30 |
341 |
0.72 |
chr6_42351556_42352213 | 3.15 |
Gm44284 |
predicted gene, 44284 |
1022 |
0.29 |
chr10_93887097_93887340 | 3.14 |
Metap2 |
methionine aminopeptidase 2 |
268 |
0.87 |
chr6_34869391_34869620 | 3.13 |
Tmem140 |
transmembrane protein 140 |
2453 |
0.18 |
chr11_94468500_94470223 | 3.12 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4280 |
0.16 |
chr7_70280148_70281631 | 3.11 |
Gm29327 |
predicted gene 29327 |
31113 |
0.13 |
chr5_116026440_116026761 | 3.10 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
2092 |
0.2 |
chr15_25942218_25942426 | 3.09 |
Retreg1 |
reticulophagy regulator 1 |
357 |
0.88 |
chr2_164441103_164441802 | 3.09 |
Sdc4 |
syndecan 4 |
1734 |
0.18 |
chr16_91086509_91086728 | 3.09 |
4932438H23Rik |
RIKEN cDNA 4932438H23 gene |
8504 |
0.12 |
chr17_84180639_84182724 | 3.08 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr7_66196444_66196724 | 3.08 |
Gm45080 |
predicted gene 45080 |
6029 |
0.17 |
chr18_80259007_80259392 | 3.08 |
Slc66a2 |
solute carrier family 66 member 2 |
2881 |
0.16 |
chr14_27237814_27239092 | 3.07 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr3_127895351_127895507 | 3.06 |
Fam241a |
family with sequence similarity 241, member A |
859 |
0.5 |
chr2_28000046_28000266 | 3.05 |
Col5a1 |
collagen, type V, alpha 1 |
17285 |
0.19 |
chr10_80330985_80331440 | 3.03 |
Reep6 |
receptor accessory protein 6 |
1010 |
0.24 |
chr12_33315895_33316065 | 3.02 |
Atxn7l1 |
ataxin 7-like 1 |
575 |
0.78 |
chr6_28424707_28425215 | 3.02 |
Gcc1 |
golgi coiled coil 1 |
808 |
0.41 |
chr2_122148370_122148749 | 3.01 |
B2m |
beta-2 microglobulin |
873 |
0.46 |
chr17_25224966_25225409 | 3.01 |
Unkl |
unkempt family like zinc finger |
2408 |
0.13 |
chr5_113973724_113975031 | 3.00 |
Ssh1 |
slingshot protein phosphatase 1 |
7621 |
0.13 |
chr14_27000422_27001594 | 2.99 |
Hesx1 |
homeobox gene expressed in ES cells |
646 |
0.71 |
chr4_135312550_135313231 | 2.98 |
Gm12982 |
predicted gene 12982 |
4920 |
0.13 |
chr18_78121610_78122242 | 2.98 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
1405 |
0.49 |
chr7_83654170_83654468 | 2.98 |
Il16 |
interleukin 16 |
1006 |
0.4 |
chr6_34599135_34600037 | 2.97 |
Cald1 |
caldesmon 1 |
966 |
0.58 |
chr9_46228849_46229438 | 2.96 |
Apoa1 |
apolipoprotein A-I |
422 |
0.68 |
chr17_28308491_28309011 | 2.96 |
Fance |
Fanconi anemia, complementation group E |
4768 |
0.11 |
chr8_33927475_33928014 | 2.96 |
Rbpms |
RNA binding protein gene with multiple splicing |
1532 |
0.38 |
chr7_83881977_83882131 | 2.95 |
Tlnrd1 |
talin rod domain containing 1 |
2251 |
0.16 |
chr13_6549550_6549952 | 2.93 |
Pitrm1 |
pitrilysin metallepetidase 1 |
1516 |
0.42 |
chr3_100921543_100921984 | 2.93 |
Trim45 |
tripartite motif-containing 45 |
439 |
0.82 |
chr1_150991583_150991734 | 2.93 |
Hmcn1 |
hemicentin 1 |
1393 |
0.42 |
chr4_46402358_46402517 | 2.93 |
Hemgn |
hemogen |
1799 |
0.25 |
chr4_102570084_102571297 | 2.92 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
595 |
0.85 |
chr17_88628874_88630550 | 2.92 |
Ston1 |
stonin 1 |
2348 |
0.25 |
chr7_132774373_132774578 | 2.92 |
Fam53b |
family with sequence similarity 53, member B |
2441 |
0.3 |
chr15_102460089_102460942 | 2.92 |
Prr13 |
proline rich 13 |
432 |
0.68 |
chr3_127930606_127930968 | 2.91 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14615 |
0.14 |
chr5_34976674_34977152 | 2.90 |
Rgs12 |
regulator of G-protein signaling 12 |
1921 |
0.31 |
chr19_29068022_29068464 | 2.90 |
Gm9895 |
predicted gene 9895 |
896 |
0.45 |
chr8_35494191_35494342 | 2.90 |
Eri1 |
exoribonuclease 1 |
786 |
0.66 |
chr15_82378536_82379272 | 2.89 |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
1339 |
0.18 |
chr11_69546279_69547462 | 2.89 |
Dnah2 |
dynein, axonemal, heavy chain 2 |
2238 |
0.14 |
chr11_65268412_65269105 | 2.88 |
Myocd |
myocardin |
1096 |
0.55 |
chr15_78245124_78245331 | 2.87 |
Ncf4 |
neutrophil cytosolic factor 4 |
383 |
0.81 |
chr5_102724663_102726037 | 2.86 |
Arhgap24 |
Rho GTPase activating protein 24 |
377 |
0.93 |
chr17_70847070_70847424 | 2.86 |
Tgif1 |
TGFB-induced factor homeobox 1 |
77 |
0.94 |
chr7_31040855_31042728 | 2.86 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr2_121235231_121235799 | 2.86 |
Trp53bp1 |
transformation related protein 53 binding protein 1 |
174 |
0.93 |
chr6_116651389_116652299 | 2.86 |
Depp1 |
DEPP1 autophagy regulator |
1148 |
0.32 |
chr5_143819014_143819653 | 2.86 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
1386 |
0.38 |
chr2_26019769_26020174 | 2.86 |
Ubac1 |
ubiquitin associated domain containing 1 |
1561 |
0.29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.1 | 8.3 | GO:0003166 | bundle of His development(GO:0003166) |
1.8 | 5.5 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.7 | 5.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.5 | 4.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.4 | 5.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.4 | 4.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.3 | 1.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.3 | 5.3 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.3 | 5.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 6.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.2 | 3.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 1.2 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.2 | 3.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 6.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.2 | 4.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.2 | 3.6 | GO:0002432 | granuloma formation(GO:0002432) |
1.2 | 3.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.2 | 4.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.2 | 3.5 | GO:0008228 | opsonization(GO:0008228) |
1.1 | 4.3 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 3.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.1 | 3.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.0 | 3.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.0 | 2.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.0 | 4.0 | GO:0009414 | response to water deprivation(GO:0009414) |
1.0 | 4.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.0 | 3.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.0 | 2.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.0 | 3.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.0 | 3.8 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.9 | 1.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.9 | 2.7 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 2.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.9 | 0.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.9 | 1.8 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.9 | 2.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.9 | 2.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.9 | 2.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 12.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.8 | 2.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.8 | 16.6 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 2.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 3.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 2.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 2.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 3.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.8 | 3.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.8 | 4.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.8 | 5.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 2.3 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.8 | 5.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.7 | 4.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.7 | 2.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.7 | 3.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 3.6 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.7 | 1.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.7 | 2.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.7 | 6.4 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.7 | 2.1 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.7 | 2.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 2.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 0.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.7 | 1.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.7 | 0.7 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
0.7 | 2.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 1.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 2.0 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 2.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.7 | 2.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 0.7 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.7 | 0.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.7 | 0.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.7 | 2.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.7 | 2.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 0.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.6 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.6 | 5.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 4.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 1.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 1.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 5.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.6 | 2.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.6 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.6 | 1.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
0.6 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 1.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.8 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.6 | 1.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 1.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 1.8 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.6 | 5.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.6 | 4.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 3.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.6 | 1.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 4.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.6 | 2.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.6 | 2.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 2.9 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.6 | 1.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 0.6 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.6 | 1.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 2.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.5 | 2.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 1.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.1 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.5 | 3.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 1.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 0.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 3.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.5 | 2.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 3.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 1.5 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.5 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 1.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 4.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.5 | 0.5 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.5 | 3.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 6.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 2.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 2.4 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.5 | 1.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 2.4 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.5 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 1.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 3.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.5 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 1.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 3.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.5 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 4.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.5 | 1.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 1.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 2.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 1.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.5 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 1.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 2.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.5 | 1.8 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 2.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 0.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 3.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 2.7 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 0.9 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 1.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.4 | 0.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 0.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.4 | 1.3 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 0.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 1.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 1.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 2.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 1.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.4 | 2.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 2.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.4 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 2.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 2.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 1.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 1.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.4 | 0.8 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 1.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.4 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 6.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 2.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.4 | 2.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 2.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 1.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 2.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 0.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.4 | 1.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 2.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 2.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 2.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 2.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 1.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 2.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 2.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.2 | GO:0046618 | drug export(GO:0046618) |
0.4 | 2.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 2.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 1.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 4.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 1.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 1.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 0.4 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.4 | 1.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 1.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.4 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 0.7 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 0.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 2.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 1.4 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.4 | 1.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 0.7 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.4 | 1.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 1.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.1 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 2.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 3.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 1.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 1.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 3.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 6.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.3 | 2.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 4.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 2.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 0.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.3 | 2.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 2.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 2.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 0.7 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.3 | 1.0 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 5.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 3.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.3 | 1.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 1.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 1.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.6 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.3 | 3.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 4.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 0.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 0.6 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.3 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.3 | 1.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 2.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 4.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.8 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.3 | 1.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.9 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.3 | 3.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.3 | 1.2 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 2.4 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 3.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 1.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 0.9 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 1.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 3.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.3 | 1.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 2.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 1.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.6 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 0.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 4.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 1.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 2.0 | GO:0006833 | water transport(GO:0006833) |
0.3 | 1.4 | GO:0052805 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 3.1 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.3 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 2.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 0.8 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 0.8 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 1.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 0.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.4 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 2.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 2.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.8 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 3.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 1.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 4.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.9 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 0.3 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 1.8 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 0.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 2.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 0.8 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.3 | 2.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 1.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 3.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 1.3 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.3 | 1.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 2.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 1.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 0.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.3 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.5 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.3 | 1.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 2.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 1.8 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 0.2 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.2 | 0.7 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.0 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 2.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.2 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.2 | 0.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.5 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.2 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 1.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 1.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 2.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 2.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 6.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 1.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.7 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 2.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.2 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 0.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 4.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 1.4 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.7 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.2 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.7 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 1.1 | GO:1902373 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.2 | 1.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.7 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.4 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 3.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 2.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:1901421 | regulation of response to alcohol(GO:1901419) positive regulation of response to alcohol(GO:1901421) |
0.2 | 4.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 6.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 1.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.8 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 0.8 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.2 | GO:0044531 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.4 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 1.4 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.2 | 1.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 1.6 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.2 | 0.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 1.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 1.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.3 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.4 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 0.8 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 1.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 1.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 2.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.4 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.2 | 0.4 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.4 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.6 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 2.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 1.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 3.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.2 | 3.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 1.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 1.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 3.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 4.3 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.2 | 0.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.5 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 1.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 1.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 1.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.3 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.5 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.2 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 1.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.3 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 7.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 2.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 2.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 1.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.2 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 4.6 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.2 | 0.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 1.9 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.2 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.2 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 1.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 2.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 1.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.9 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 3.0 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.8 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 3.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 1.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 1.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 2.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.6 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 2.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 2.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 2.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 1.8 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 1.7 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 1.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 0.3 | GO:0090114 | cargo loading into vesicle(GO:0035459) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.7 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 0.5 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 4.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.4 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 1.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 3.7 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 1.0 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.5 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 2.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.5 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.1 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.1 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 1.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 1.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 1.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 1.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 0.6 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 1.3 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.3 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 4.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 1.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 1.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.3 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 3.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 1.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.4 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.8 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.1 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 1.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 2.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 0.4 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 2.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.1 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 1.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 3.0 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.2 | GO:1903224 | regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 0.4 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.5 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.4 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 2.5 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 1.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.2 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.8 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 2.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 2.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 2.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.7 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.4 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.4 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 1.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.1 | 0.1 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.1 | 0.5 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 1.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 1.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.2 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.6 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.4 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.5 | GO:0075733 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.2 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.9 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.2 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 1.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.3 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 1.8 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 1.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 2.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 1.0 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:0051610 | serotonin uptake(GO:0051610) |
0.1 | 0.4 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 1.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.9 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.1 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.1 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.1 | 1.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:2000136 | cell proliferation involved in heart morphogenesis(GO:0061323) regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.0 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 1.0 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.0 | 0.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.2 | GO:1900408 | negative regulation of cellular response to oxidative stress(GO:1900408) negative regulation of response to oxidative stress(GO:1902883) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 1.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.6 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.6 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.0 | 0.0 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.0 | 0.3 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.8 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.0 | 0.0 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 1.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.0 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 4.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.0 | 0.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.1 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.0 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.4 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.0 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.8 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.0 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0070345 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.0 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.8 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.0 | 0.1 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 2.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.0 | GO:0071604 | transforming growth factor beta production(GO:0071604) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.6 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 1.4 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.0 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.0 | GO:0044851 | hair cycle phase(GO:0044851) |
0.0 | 0.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.0 | 0.1 | GO:0070542 | response to fatty acid(GO:0070542) |
0.0 | 0.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.2 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.0 | 0.0 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.0 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.0 | 0.2 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.0 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.0 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 1.3 | GO:0042110 | T cell activation(GO:0042110) T cell aggregation(GO:0070489) |
0.0 | 2.9 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.2 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.0 | 0.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.1 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.0 | 0.0 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.6 | 4.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.5 | 4.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 2.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.0 | 7.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.0 | 5.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 3.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 3.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.8 | 2.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 3.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 3.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 2.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.7 | 3.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.9 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 6.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 3.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 3.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 3.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.6 | 1.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 3.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 12.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.5 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 1.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 1.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.5 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 2.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 2.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 2.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 1.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 4.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 4.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 0.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 3.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 2.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 3.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 3.9 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 2.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.3 | 2.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 3.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 0.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.3 | 1.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 0.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 0.8 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 2.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 1.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.8 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.3 | 1.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 14.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.0 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 2.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 1.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 3.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 3.8 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 1.1 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 3.0 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 4.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 2.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 4.4 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 14.8 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.9 | GO:0031674 | I band(GO:0031674) |
0.2 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 10.8 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 2.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 5.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 2.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.5 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 1.0 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 2.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 8.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.7 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 1.1 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 8.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 1.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 10.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 5.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 2.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 11.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 5.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 10.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.5 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 33.0 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 5.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 4.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.9 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 2.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 2.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 5.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 22.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.5 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.8 | GO:0030894 | replisome(GO:0030894) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 2.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 4.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 2.0 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 11.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 18.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 3.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 3.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 26.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 7.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 4.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 3.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.9 | GO:0044449 | contractile fiber part(GO:0044449) |
0.1 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 5.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 2.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0005818 | aster(GO:0005818) |
0.1 | 1.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 2.8 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 7.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 92.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 4.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 3.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 3.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 1.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 5.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.4 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.0 | 0.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.8 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0000805 | X chromosome(GO:0000805) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.2 | 3.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 3.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.1 | 4.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.1 | 4.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.1 | 2.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.0 | 3.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.0 | 1.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.0 | 2.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.9 | 2.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.9 | 2.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.9 | 5.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 4.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 6.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 6.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.8 | 3.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.8 | 2.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 3.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 3.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 2.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 1.5 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 5.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 3.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 2.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 6.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 5.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 2.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.7 | 3.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 3.9 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 2.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 2.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 7.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 3.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 2.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 1.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 1.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 2.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 1.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 2.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.6 | 2.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 1.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.6 | 1.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 2.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.6 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.6 | 2.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.5 | 2.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.6 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 1.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 1.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 2.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 18.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 5.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.5 | 4.5 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.5 | 2.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 2.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 3.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 2.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 1.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 2.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 3.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 3.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 4.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.8 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 1.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 3.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 0.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.4 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 1.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 2.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 3.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 8.5 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 2.4 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 5.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 4.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 2.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 5.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 2.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.4 | 1.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 1.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 7.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 4.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.3 | 0.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 4.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 1.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 6.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 0.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 2.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 4.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 4.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 2.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.0 | GO:0034859 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 5.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 15.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 2.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 1.6 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.3 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 3.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 0.9 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 1.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 1.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 1.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.2 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 2.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 6.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 2.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 2.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 6.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 1.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 3.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 1.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 1.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 3.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 0.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 1.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 7.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 5.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 4.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 2.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 0.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 2.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 2.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 2.6 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 2.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 6.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 4.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 4.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 2.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 3.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 8.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 4.5 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.7 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 2.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 1.1 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 15.0 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 1.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 1.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 3.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 6.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 3.2 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 4.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 8.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 2.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 4.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 2.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.6 | GO:0044606 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 2.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) type 2A serotonin receptor binding(GO:0031826) |
0.1 | 1.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 1.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 3.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 7.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 2.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 6.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 6.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 3.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 4.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 3.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.5 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 1.5 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 3.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.1 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.1 | 4.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.3 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 2.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 19.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.9 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.9 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.7 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 2.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 3.5 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.3 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.1 | 5.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 3.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.3 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.8 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.9 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 9.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 15.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.9 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 4.0 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 6.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 1.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.8 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.8 | GO:0034876 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 7.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 2.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 3.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 0.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 3.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 1.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.3 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 1.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.4 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.8 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.3 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 4.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 2.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 4.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 1.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.8 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 3.4 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 1.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 1.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.6 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 1.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 4.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 24.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 3.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 14.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 3.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 3.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 3.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 1.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 15.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 3.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 9.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 13.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 3.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 3.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 4.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 2.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 8.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 5.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 12.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 4.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 11.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 9.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 4.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 9.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 4.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 2.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 11.6 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 5.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 1.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 7.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 4.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 9.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 4.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 5.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 4.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 3.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 1.4 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 3.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 4.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 4.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 5.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 2.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 10.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 3.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 7.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 9.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.6 | 8.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.6 | 7.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 0.6 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.6 | 10.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 5.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 6.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 9.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 1.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 1.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 4.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 13.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 11.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 10.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 5.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 7.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 2.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 2.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 7.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 4.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 3.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 4.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 2.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 7.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 6.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 19.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 3.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 2.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 5.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 2.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 4.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 7.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 4.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 24.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 10.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 1.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 1.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 8.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 5.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 21.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 3.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 6.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 6.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 6.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 0.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 3.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.5 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 2.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 4.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 2.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 4.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 10.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 9.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 4.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 1.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 3.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 3.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 6.6 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 10.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 6.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 3.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 3.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 4.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 2.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 5.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.3 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.6 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.0 | 0.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.0 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |